Zhiqiang Wang
- Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes 20
- Geriatrics and Gerontology top 1%
- Obstetrics and Gynecology top 1%
-
- Birth, Development, and Health 46
- Physiology top 1%
-
- Obesity, Physical Activity, Diet 33
- Nutritional Studies and Diet 24
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 32
-
- Blood Pressure and Hypertension Studies 21
-
- Gastric Cancer Management and Outcomes 20
-
- Nanoplatforms for cancer theranostics 17
Zhiqiang Wang
572 papers receiving 12.4k citations
Hit Papers
Peers
Comparison fields: 5 of 213
- Nephrology 775
- Geriatrics and Gerontology 321
- Obstetrics and Gynecology 533
- Pediatrics, Perinatology and Child Health 1.3k
- Physiology 1.6k
Countries citing papers authored by Zhiqiang Wang
This map shows the geographic impact of Zhiqiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiqiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiqiang Wang more than expected).
Fields of papers citing papers by Zhiqiang Wang
This network shows the impact of papers produced by Zhiqiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiqiang Wang. The network helps show where Zhiqiang Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhiqiang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 28 | |
| 11 | 2023 | 17 | |
| 12 | 2023 | 9 | |
| 13 | Leflunomide Inhibits Proliferation and Induces Apoptosis via Suppressing Autophagy and PI3K/Akt Signaling Pathway in Human Bladder Cancer Cells | 2020 | 1 |
| 14 | Gigantol Attenuates the Metastasis of Human Bladder Cancer Cells, Possibly Through Wnt/EMT Signaling | 2020 | 1 |
| 15 | Bit1 Silencing Enhances the Proliferation, Migration, and Invasion of Glioma Cells Through Activation of the IL-6/STAT3 Pathway | 2020 | 1 |
| 16 | 2018 | 9 | |
| 17 | Improvement of psychological status after infliximab treatment in patients with newly diagnosed Crohn’s disease | 2018 | 1 |
| 18 | [Phenotypic modulation of bladder smooth muscle in diabetic rats]. | 2016 | 2 |
| 19 | 2013 | 8 | |
| 20 | 2011 | 63 |
About Zhiqiang Wang
Zhiqiang Wang is a scholar working on Nephrology, Obstetrics and Gynecology and Endocrinology, Diabetes and Metabolism, having authored 604 papers that have together received 12.8k indexed citations. Recurring topics across this work include Birth, Development, and Health (46 papers), Obesity, Physical Activity, Diet (33 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (32 papers), Nutritional Studies and Diet (24 papers), Blood Pressure and Hypertension Studies (21 papers), Gastric Cancer Management and Outcomes (20 papers), Chronic Kidney Disease and Diabetes (20 papers) and Nanoplatforms for cancer theranostics (17 papers). The work is most often cited by research in Nephrology (775 citations), Geriatrics and Gerontology (321 citations) and Obstetrics and Gynecology (533 citations). Zhiqiang Wang has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Wendy E. Hoy, Daniela Salvemini, Mark G. Currie, Jun Ma, Pamela T. Manning, David Bourdon, Haijun Wang, Bin Dong, John D. Mathews and Alan Cass. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.